Ionis Pharmaceuticals | IONS - Vertriebs- Und Verwaltungskosten





Vertriebs- Und Verwaltungskosten Veränderung Datum
Agios Pharmaceuticals USD 38.46M 4.51M 2026-03
Alnylam Pharmaceuticals USD 347.92M 65.41M 2026-06
Arrowhead Research USD 46.63M 4.88M 2026-06
Astellas Pharma JPY 215.07B 19.63B 2026-06
BioCryst Pharmaceuticals USD 63.98M 31.8M 2026-06
BioMarin Pharmaceutical USD 395.55M 137.27M 2026-06
Celltrion KRW 9.32B 3.39B 2026-03
Cspc Pharmaceutical CNY 1.87B 95.62M 2025-12
Deva Holding AS TRY 462.26M 48.18M 2023-09
Divis Laboratories Ltd INR 3.4B 10M 2025-06
Exelixis USD 147.63M 8.03M 2026-06
Halozyme Therapeutics USD 57M 10.71M 2026-06
Ionis Pharmaceuticals USD 130.07M 20.92M 2026-06
Kangmei Pharma CNY 237.06M 37.35M 2026-03
Knight Therapeutics CAD 35.45M 4.43M 2025-12
Laboratorios Farma EUR 35.32M 2.75M 2025-06
Malin Corporation EUR 1.1M 400K 2024-12
Medical Developments International AUD 2.84M 4.19M 2025-12
Moderna USD 216M 43M 2026-06
Nektar Therapeutics USD 11.87M 1.7M 2026-03
Neuren Pharmaceuticals AUD 3.74M 2.5M 2025-12
Neurocrine Biosciences USD 383.1M 64.6M 2026-06
Novartis USD 3.24B 101M 2026-06
Omeros USD 11.32M 2.48M 2024-09
OPKO Health USD 48.61M 1.91M 2026-03
Organigram Holdings CAD 22.01M 14.28M 2026-03
Ovoca Bio EUR 617K 15K 2025-12
Pfizer USD 3.41B 496M 2026-06
Pharma Mar EUR 17.12M 1.82M 2026-06
PTC Therapeutics USD 73.89M 13.31M 2026-03
Qiagen NV USD 142.33M 60K 2026-06
Regeneron Pharmaceuticals USD 662.1M 14.4M 2026-06
Roche Holding CHF 6.37B 908M 2026-06
Sarepta Therapeutics USD 107.6M 53.57M 2026-06
Sartorius EUR 221.3M 0 2026-06
Sino Biopharmaceutical CNY 7.54B 2.23B 2025-06
Tilray USD 24.85M 1.7M 2025-09
Ultragenyx Pharmaceutical USD 88M 1000K 2026-03
Vertex Pharmaceuticals USD 582.2M 88.5M 2026-06
Zealand Pharma A/S 104M 12.19M 2026-03
Zz Pientze Pharmaceu CNY 223.14M 8.82M 2026-06